Accessibility Menu
Elevance Health logo

Elevance Health

(NYSE) ELV

Current Price$372.56
Market Cap$80.92BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2001)+2,205%
5 Year+2%
1 Year+26%
1 Month-5%
Elevance Health last closing stock price
MetricPriceDate
Last closeUSD 373.112026-07-17
Elevance Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-10.36%USD 416.232026-07-10
1 month-4.64%USD 391.272026-06-17
3 month+15.97%USD 321.742026-04-17
Year to date+7.53%USD 346.992025-12-31
1 year+25.95%USD 296.232025-07-17
3 year-11.67%USD 422.432023-07-18
5 year+1.86%USD 366.312021-07-16
Since inception+2,205.06%USD 16.182001-10-30

Elevance Health Financials at a Glance

Market Cap

$80.92BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$201.11B

Net Income (TTM)

$4.96B

EPS (TTM)

$22.50

P/E Ratio

16.58

Dividend

$6.86

Beta (Volatility)

0.43 (Low)

Price

$372.56

Volume

1,940,385

Open

$371.70

Previous Close

$373.11

Daily Range

$365.38 - $377.76

52-Week Range

$273.71 - $436.24

Estimated Earnings Date

Oct 20, 2026

ELV: Motley Fool Moneyball Superscore

64

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Elevance Health

Elevance Health helps millions of people get medical care and health insurance. It connects families to doctors, pharmacies, and support for their well-being. The company makes it easier for people to manage their daily health needs.

What Elevance Health Does

  • Health Benefits: Provides health insurance plans for individuals, employers, and government programs like Medicare and Medicaid.
  • CarelonRx: Offers pharmacy services, including home delivery and specialty medicine management, for both internal and external customers.
  • Carelon Services: Delivers specialized health support, such as behavioral health and home care, to manage complex medical needs.
  • Federal Health Products: Administers the Federal Employee Program for United States government employees and their families.

Strategic Moves and Growth

  • Acquired Paragon Healthcare in March 2024 to add infusion centers and injectable therapies to its pharmacy portfolio.
  • Completed the purchase of CareBridge at the end of 2024 to provide virtual care for complex Medicaid and Medicare patients.
  • Expanded medical plan operations into parts of Florida, Maryland, and Texas during 2025 using the Simply Healthcare and Wellpoint brands.
  • Formed a joint venture called Mosaic Health with Clayton, Dubilier & Rice to manage advanced primary care services.

A Local Focus with National Reach

Elevance Health uses a local-market approach to build strong networks with doctors and hospitals in specific communities. This strategy combined with national scale allows it to reward clinical quality through payment models that focus on patient outcomes.

The Recent Financial Record

  • Revenue grew to $49.7 billion in Q4 2025, a 9.5% increase from Q4 2024.
  • Net income rose to $547 million in Q4 2025, up 30.9% from $418 million in Q4 2024.
  • Operating income fell to $581 million in Q4 2025, a 38.6% drop from the previous year.
  • Operating cash flow was $84 million in Q4 2025, down 88.1% compared to $706 million in Q4 2024.

Bottom Line

Elevance Health has transitioned from a traditional insurer into a broad health services company. By integrating pharmacy and clinical care with its insurance business, it has built a platform for managing the total health of its 45 million medical members.

AI Generated • Apr 18, 2026

Industry

Healthcare Providers and Services

Employees

97,100

CEO

Gail Koziara Boudreaux, MBA

Headquarters

Indianapolis, IN 46204, US

ELV Financials

Key Financial Metrics (TTM)

Gross Margin

38.95%

Operating Margin

3.51%

Net Income Margin

2.47%

Return on Equity

11.24%

Return on Capital

10.52%

Return on Assets

3.93%

Earnings Yield

6.03%

Dividend Yield

1.84%

Payout Ratio

30.36%

Stock Overview

Market Cap

$80.92BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

216.87M

Volume

1.94M

Avg. Volume

1.80M

Financials (TTM)

Gross Profit

$78.34B

Operating Income

$7.06B

EBITDA

$8.01B

Operating Cash Flow

$7.46B

Capital Expenditure

-$1.18B

Free Cash Flow

$6.29B

Cash & ST Invst.

$37.51B

Total Debt

$31.04B

Elevance Health Performance Analysis

Elevance Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 156,595,000,00013.0%
20232023-12-31USD 171,340,000,0009.4%
20242024-12-31USD 176,810,000,0003.2%
20252025-12-31USD 199,125,000,00012.6%
Elevance Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.9%
Q42025-12-31-1.9%
Q12026-03-310.9%
Q22026-06-300.6%
Elevance Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 24.28-1.8%
20232023-12-31USD 25.223.9%
20242024-12-31USD 25.681.8%
20252025-12-31USD 25.21-1.8%
Elevance Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-31.1%
Q42025-12-31-53.6%
Q12026-03-31223.9%
Q22026-06-30-16.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$50.47B

+1.4%

Gross Profit

$44.98B

+244.2%

Gross Margin

89.12%

N/A

Market Cap

$80.92BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$833.33K

N/A

Employees

97,100

N/A

Net Income

$1.46B

-16.1%

EBITDA

$2.10B

-30.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$37.51B

+338.2%

Total Debt

$31.04B

+2.8%

Accounts Receivable

$23.39B

+46.9%

Inventory

$0.00

N/A

Long Term Debt

$30.67B

+8.8%

Short Term Debt

$375.00M

-81.3%

Return on Assets

3.93%

N/A

Return on Invested Capital

8.59%

N/A

Free Cash Flow

$1.63B

-9.0%

Operating Cash Flow

$1.91B

-6.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CICigna Corporation
$281.45-0.84%
REGNRegeneron Pharmaceuticals, Inc.
$676.69-0.33%
CORCencora, Inc.
$307.90-0.03%
GSKGSK plc
$51.76-1.91%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.53-0.02%
AALAmerican Airlines Group
$14.98-0.04%
NVDANvidia
$202.81-0.02%
NOKNokia
$10.12-0.03%

Questions About ELV

What is the current price of Elevance Health?

Elevance Health is trading at $373.11 per share.

What is the 52-week range for Elevance Health?

Over the past 52 weeks, Elevance Health has traded between $273.71 and $436.24.

How much debt does Elevance Health have?

As of the most recent reporting period, Elevance Health reported total debt of $31.04B.

How much cash does Elevance Health have on hand?

Elevance Health reported $10.23B in cash and cash equivalents in its most recent financial results.

What is Elevance Health’s dividend yield?

Elevance Health currently has a dividend yield of 1.84%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.